Back

Korean hair-loss stocks surge as much as 66.96% in seven sessions

Verifying
  • JW Shinyak, Hyundai Pharmaceutical and Samik Pharm extended their hair-loss stock rally.
  • 66.96% was JW Shinyak’s seven-session gain through the 8th.
  • U.S. hair-loss drug developers gained investor attention after obesity treatments.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.